Evidence map›Paper›PMID 40026367›Full record

ArticleFrontiers in oral health2025

Higher Reactive Oxygen Species and cellular aging in oral mucosal cells of young smokers: a comparative analytical study.

Bushra Imdad, Uzair Abbas, Pershad Kumar, Durre Sameen Kamran, Mahtab Khan, Niaz Hussain, Muhib Ullah Khalid

Abstract read
In one paragraph

Article in Frontiers in oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bushra ImdadDepartment of Physiology, Dow University of Health Sciences, Karachi, Pakistan.
Uzair AbbasDepartment of Physiology, Dow University of Health Sciences, Karachi, Pakistan.
Pershad KumarDepartment of Pulmonology, Jinnah Postgraduate Medical Center, Karachi, Pakistan.
Durre Sameen KamranDepartment of Pathology, Dow University of Health Sciences, Karachi, Pakistan.
Mahtab KhanDow University of Health Sciences, Karachi, Pakistan.
Niaz HussainLiaquat University of Medical and Health Sciences, Jamshoro, Pakistan.
Muhib Ullah KhalidDow University of Health Sciences, Karachi, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cigarette smoke contains chemical components that cause excessive production of Reactive Oxygen Species (ROS), altering cell physiology and affecting key pathways. This leads to hyperinflammation, DNA damage, and cellular aging, which may cause oral and pulmonary pathologies. Our study aims to investigate the impact of smoking on ROS levels and cellular aging in oral mucosal cells. We compared Reactive oxygen Species and cellular aging between smokers and non-smokers. Secondarily, we also compared the results between young and old smokers. Methods: Oral swabs were taken from 50 smokers and 50 nonsmokers using a cytology brush. We quantified the reactive oxygen species (ROS) by using oxidized 2'7' dichlorodihydrofluorescein-diacetate (DCFH-DA) dye. To assess cellular aging, mRNA levels of the CYR61 gene-a cellular aging marker, were compared through RT-PCR. Results: It was found that smokers had a higher percentage of ROS in comparison to non-smokers ( Conclusion: It has been observed that smokers have a higher amount of ROS production and cellular aging in their oral mucosal cells. In young smokers, ROS and cellular aging were found to be higher compared to older smokers. This is quite concerning and could be a major factor leading to oral pathologies in smokers.

Indexed as

cellular agingoral mucosal cellsReactive Oxygen Speciessmokingyoung smokers

Identifiers

PMID40026367
PMCPMC11868274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.